Search
for
Sort by
Research 541–570 of 1000+
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Polycystic ovary syndrome and impact on health
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome